BDBM50133066 17,20-dioxa-4,12,14,23,25-pentaazahexacyclo[21.6.1.17,14.02,6.08,13.024,29]hentriaconta-1(30),2(6),7(31),8,10,12,24,26,28-nonaene-3,5-dione::CHEMBL132223

SMILES O=C1NC(=O)C2=C1c1cn(CCOCCOCCn3cc2c2cccnc32)c2ncccc12

InChI Key InChIKey=BXLMONUQKMHQEF-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50133066   

TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50133066(17,20-dioxa-4,12,14,23,25-pentaazahexacyclo[21.6.1...)
Affinity DataIC50:  620nMAssay Description:Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein kinase C gamma type(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50133066(17,20-dioxa-4,12,14,23,25-pentaazahexacyclo[21.6.1...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of Protein kinase C gamma (PKC-gamma)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed